Eli Lilly to invest $140m in insulin manufacturing facility expansion
The 80,000ft² expansion will facilitate insulin cartridge manufacturing for people with diabetes and will help meet the diabetes demand in the country. Lilly chairman, president and chief executive
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.